Drug Trial Radar · NCT00254202
Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia
Last checked: Nov 20, 2026Latest source record: Oct 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
593
Actual
Start
Nov 18, 2005
Primary completion
Sep 26, 2006
Study completion Mar 21, 2007
Sponsor
- Lead sponsor
- Vanda PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Nov 15, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the safety and efficacy of iloperidone compared to placebo and an active comparator in the treatment of patients with schizophrenia in acute exacerbation.
Conditions
- Schizophrenia
Interventions
IloperidoneDrug
ZiprasidoneDrug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Positive and Negative Symptom Scale Total (PANSS-T) ScoreTime frame: 4 weeks
Locations
42 sites in 2 countries. Site status is shown where the registry gives one.
Vanda Investigational Site
Little Rock, Arkansas
Vanda Investigational Site
Anaheim, California
Vanda Investigational Site
Cerritos, California
Vanda Investigational Site
Garden Grove, California
Vanda Investigational Site
Glendale, California
Vanda Investigational Site
Los Angeles, California
Vanda Investigational Site
National City, California
Vanda Investigational Site
Oceanside, California
Vanda Investigational Site
Paramount, California
Vanda Investigational Site
Pico Rivera, California
Vanda Investigational Site
San Diego, California
Vanda Investigational Site
San Diego, California
Vanda Investigational Site
San Diego, California
Vanda Investigational Site
Santa Ana, California
Vanda Investigational Site
Upland, California
Vanda Investigational Site
Bradenton, Florida
Vanda Investigational Site
Fort Lauderdale, Florida
Vanda Investigational Site
Maitland, Florida
Vanda Investigational Site
Atlanta, Georgia
Vanda Investigational Site
Augusta, Georgia
Vanda Investigational Site
Hoffman Estates, Illinois
Vanda Investigational Site
Lake Charles, Louisiana
Vanda Investigational Site
Rockville, Maryland
Vanda Investigational Site
Saint Charles, Missouri
Vanda Investigational Site
St Louis, Missouri
Vanda Investigational Site
Clementon, New Jersey
Vanda Investigational Site
Brooklyn, New York
Vanda Investigational Site
Cincinnati, Ohio
Vanda Investigational Site
Philadelphia, Pennsylvania
Vanda Investigational Site
Austin, Texas
Vanda Investigational Site
Houston, Texas
Vanda Investigational Site
Irving, Texas
Vanda Investigational Site
Richmond, Virginia
Vanda Investigational Site
Tirupati, Andhra Pradesh, India
Vanda Investigational Site
Ahmedabad, Gujarat, India
Vanda Investigational Site
Manipal, Karnataka, India
Vanda Investigational Site
Chhatrapati Sambhajinagar, Maharashtra, India
Vanda Investigational Site
Pune, Maharashtra, India
Vanda Investigational Site
Jaipur, Rajasthan, India
Vanda Investgational Site
Chennai, Tamil Nadu, India
Showing 40 of 42 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.